Shows
Voices of Women PhysiciansEp 132: How to Use Food as Medicine to Reduce Inflammation, Boost Mood, and Transform Your Overall HealthDr. Tatyana Reznik is a practicing physician with over 25 years of clinical experience. She is double board-certified in Internal Medicine and Lifestyle Medicine, a mother, a Certified Life Coach, the host of the Voices of Women Physicians Podcast, and an author. She immigrated to the US over 20 years ago from Uzbekistan where she was a practicing Cardiologist. In the US, she completed residency training at the University of Nevada, Reno, and has been practicing Hospital Medicine in California since then. She is passionate about helping people improve their health and well-being.In her coaching practice, s...2025-01-1112 min
The HemOnc PulseDr. Usmani Highlights Myeloma Presentations from SOHO 2024On this episode of "The HemOnc Pulse," Saad Usmani, MD, of the Memorial Sloan Kettering Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss notable presentations on multiple myeloma from the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.
2024-11-2025 minThe HemOnc PulseCovering MDS Updates at SOHO 2024 With Dr. VenugopalOn this episode of "The HemOnc Pulse," Chadi Nabhan, MD, MBA, FACP, is joined by Sangeetha Venugopal, MD, of the Sylvester Comprehensive Cancer Center at the University of Miami, to highlight data on myelodysplastic syndromes (MDS) presented at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.
2024-11-0125 min
Access Must-Have Full Audiobooks in Health & Wellness, Disorders & DiseasesThe Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention by Chadi Nabhan Md Mba FacpPlease visithttps://thebookvoice.com/podcasts/1/audiobook/782987to listen full audiobooks.
Title: The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention
Author: Chadi Nabhan Md Mba Facp
Narrator: Chadi Nabhan Md Mba Facp
Format: Unabridged Audiobook
Length: 11 hours 49 minutes
Release date: October 15, 2024
Genres: Disorders & Diseases
Publisher's Summary:
A compassionate guide to the cancer journey, from screening and prevention to diagnosis and recovery.A cancer diagnosis can change our lives and the lives of our loved ones in an instant. It leaves us seeking answers to myriad questions and searching for hope. In The Cancer Journey, Dr. Chadi Nabhan demystifies this complex...2024-10-1511h 49Explore the Latest Full Audiobooks in Health & Wellness, Medicine & NaturopathyThe Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention by Chadi Nabhan Md Mba FacpPlease visithttps://thebookvoice.com/podcasts/1/audiobook/782987to listen full audiobooks.
Title: The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention
Author: Chadi Nabhan Md Mba Facp
Narrator: Chadi Nabhan Md Mba Facp
Format: Unabridged Audiobook
Length: 11 hours 49 minutes
Release date: October 15, 2024
Genres: Medicine & Naturopathy
Publisher's Summary:
A compassionate guide to the cancer journey, from screening and prevention to diagnosis and recovery.A cancer diagnosis can change our lives and the lives of our loved ones in an instant. It leaves us seeking answers to myriad questions and searching for hope. In The Cancer Journey, Dr. Chadi Nabhan demystifies this complex...2024-10-1511h 49The HemOnc PulseAML News From SOHO 2024 With Dr. DaverOn this episode of "The HemOnc Pulse," Naval Daver, MD, of the MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss news on acute myeloid leukemia coming out of the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.
2024-10-1123 minThe HemOnc PulseDr. Shadman Shares SOHO 2024 Data On CLLOn this episode of "The HemOnc Pulse," Mazyar Shadman, MD, MPH, of the Fred Hutchinson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to highlight some of the notable presentations on chronic lymphocytic leukemia coming out of the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.
2024-09-2729 min
Precision Medicine Made SimpleHow Doctors are Using Genetic Data to Transform Patient Care with Philip Bretsky MD PhD MPH FACPHow Doctors are Using Genetic Data to Transform Patient Care with Philip Bretsky MD PhD MPH FACPIn this episode, we're joined by Dr. Philip Bretsky, a board-certified internist from Santa Monica with expertise in epidemiology and Alzheimer's research. Dr. Bretsky discusses how precision medicine is transforming healthcare by integrating genetics, biomarkers, and lifestyle factors. He explores the challenges and opportunities in implementing this approach, the evolving role of general practitioners, and how patients can advocate for personalized care. Dr. Bretsky also shares valuable resources for both health-conscious individuals and primary care providers interested in precision medicine...2024-09-2358 minThe HemOnc PulseDr. Bose on MPN Highlights From SOHO 2024On this episode of "The HemOnc Pulse," Prithviraj Bose, MD, of the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss some of the important data on myeloproliferative neoplasms that were presented at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.
2024-09-1726 minThe HemOnc PulsePart Two: The Question of MRD in CLL TherapyIn part two of this episode, Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Center; Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center; and Alan Skarbnik, MD, of Novant Health, continue to explore the role of measurable residual disease (MRD) in the treatment of patients with chronic lymphocytic leukemia (CLL).
“The HemOnc Pulse” was live for in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic and clinical experts who delved into unanswered questions in various hematologic malignancies.
2024-08-2220 min
Taking Control Of Your Diabetes® - The Podcast!Doing All the Right Things, but Your Diabetes Is Still Out of Whack…Could It Be Hypercortisolism? With Daniel Einhorn MD, FACP, FACEDoing All the Right Things, but Your Diabetes Is Still Out of Whack…Could It Be Hypercortisolism? – Featuring Daniel Einhorn MD, FACP, FACETAKING CONTROL OF YOUR DIABETES® - THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusDiscover why 1 in 4 people living with uncontrolled diabetes might have an overlooked, treatable condition. In this eye-opening episode of the Taking Control of Your Diabetes podcast, Dr. Steve Edelman and endocrinology expert Dr. Daniel Einhorn reveal the hidden link between hypercortisolism and stubborn diabetes.This eye-o...2024-08-1227 minThe HemOnc PulseDr. Osman on Identifying and Treating High-Risk MDSOn “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, met with Afaf Osman, MD, an Assistant Professor at the University of Utah Huntsman Cancer Center, to discuss how high-risk myelodysplastic syndromes (MDS) are distinct from lower-risk classifications and how to approach treatment.
2024-08-0925 minThe HemOnc PulseDr. Rami Komrokji on Trends in Real-World MDS CareOn “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, spoke with Rami Komrokji, MD, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center in Tampa, Florida, about the state of myelodysplastic syndromes (MDS) care. Moffitt Cancer Center is home to a large MDS database, with clinical information on nearly 6,000 patients, a trove of real-world MDS data.
2024-07-2528 minThe HemOnc PulsePart One: The Question of MRD in CLL TherapyPart one of this episode explores questions in measurable residual disease (MRD) and chronic lymphocytic leukemia (CLL) with Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Center; Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center; and Alan Skarbnik, MD, of Novant Health.
“The HemOnc Pulse” was live for in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic and clinical experts who delved into unanswered questions in various hematologic malignancies.
2024-07-1835 minThe HemOnc PulseUnpacking Bispecifics at ‘The HemOnc Pulse’ Live Meeting“The HemOnc Pulse” was live for the first time in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic and clinical experts who delved into unanswered questions in a range of hematologic malignancies. As part of the program, Michael Bishop MD, of the University of Chicago, and Aaron Goodman, MD, of the University of California, San Diego, were joined by Rafael Fonseca, MD, of the Mayo Clinic, to hold a panel on bispecific therapies and explore unanswered questions related to them.
2024-05-2446 minThe HemOnc PulseDiscussing the Role of MRD in CLL With Talal Hilal, MDDr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).
2024-05-1621 minThe HemOnc PulseUnanswered Questions in MDS at ‘The HemOnc Pulse’ Live 2024 in ChicagoRecorded at the first “HemOnc Pulse” Live meeting, this podcast episode features a panel discussion on unanswered questions in myelodysplastic syndromes (MDS) with Rami Komrokji, MD, Vice-Chair of the Malignant Hematology Department at Moffitt Cancer Center; Sanam Loghavi, MD, an Associate Professor of Pathology at the University of Texas MD Anderson Cancer Center; Jamile Shammo, MD, FACP, FASCP, a Professor at the Northwestern University Feinberg School of Medicine; Sangeetha Venugopal, MD, MS, an Assistant Professor of Medicine at the University of Miami Sylvester Comprehensive Cancer Center; and Amer Zeidan, MBBS, MHS, an Associate Professor of Medicine at Yale University.
2024-05-1331 minThe HemOnc Pulse“The HemOnc Pulse” Live 2024 in Chicago: CAR-T Unanswered Questions“The HemOnc Pulse” goes on the road to Chicago May 3-4 with host Chadi Nabhan, MD, MBA, FACP, for the first live meeting.
This podcast episode features a panel discussion on unanswered questions in chimeric antigen receptor (CAR) T-cell therapy with Caron Jacobson, MD, MMSc, Medical Director of the Immune Effector Cell Therapy Program at Dana-Farber Cancer Institute; Michael Bishop, MD, FACP, FASCO, Director of the Hematopoietic Stem Cell Transplantation Program at the University of Chicago; Joseph Mikhael, MD, MEd, FRCPC, FACP, a Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Research Inst...2024-05-0538 minThe HemOnc Pulse"The HemOnc Pulse" Live 2024 in Chicago: AML Unanswered Questions"The HemOnc Pulse" goes on the road to Chicago with host Chadi Nabhan, MD, MBA, FACP.
This podcast episode features a panel discussion on unanswered questions in acute myeloid leukemia (AML) with Naval Daver, MD, an Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center; Sanam Loghavi, MD, of the MD Anderson Cancer Center; Rami Komrokji, MD, the Vice-Chair of the Malignant Hematology Department at Moffitt Cancer Center in Tampa, Florida; and Mikkael Sekeres, MD, MS, a Professor of Medicine and Chief of the Division of Hematology at the Sylvester...2024-05-0434 minThe HemOnc PulseKrish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCLDr. Patel, of the Swedish Cancer Institute in Seattle, Washington, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss novel frontline therapies in the lymphoma space, including the bispecific antibody glofitamab.
They also discuss bispecifics versus chimeric antigen receptor (CAR) T-cell therapy, fixed duration therapy and step-up dosing, and how to sequence therapy.
2024-04-0422 minThe HemOnc PulseAaron Goodman, MD, Tells Us the 'Crux' of Castleman DiseaseIn this episode of "The HemOnc Pulse," Dr. Goodman, an Associate Professor of Medicine at the University of California San Diego, joins Chadi Nabhan, MD, MBA, FACP, to discuss Castleman Disease.
Dr. Goodman explains why the rare disease is often mismanaged, how each subtype is diagnosed and treated, and how it's comparable to hematologic cancers like lymphoma or myeloma.
2024-04-0226 minThe HemOnc PulseIs MRD Negativity the New Benchmark in ALL Treatment Strategies?Elias Jabbour, MD, an Executive Editor of Blood Cancers Today and a Professor of Leukemia at the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss the function of measurable residual disease in treating acute lymphocytic leukemia (ALL) and other progress that has been made in treating patients with Philadelphia chromosome-positive and Philadelphia chromosome-negative ALL.
Dr. Jabbour also provides a brief historical perspective on tyrosine kinase inhibitors (TKIs), explaining how the therapies have improved survival outcomes in Ph+ ALL with or without transplantation.
2024-03-1419 minThe HemOnc PulsePart Two: Drs. Dahiya, Spiegel Return to Discuss 'Black Box' Warning on CAR-T TherapiesSaurabh Dahiya, MD, FACP, of Stanford Medicine, and Jay Spiegel, MD, of the University of Miami, join The HemOnc Pulse for the second half of a two-part series on reports regarding secondary T-cell malignancies in patients after being treated with a chimeric antigen receptor (CAR) T-cell therapy and updates from the US Food and Drug Administration (FDA) on the issue.
Drs. Dahiya and Spiegel return to the show shortly following the announcement that the FDA sent requests to drug manufacturers on January 9 to update prescription labels with "Black Box" warnings on the six CAR-T therapies used to...2024-02-2932 minThe HemOnc PulseDrs. Dahiya, Spiegel Discuss CAR-T Secondary Malignancies Risk
An all-new episode of The HemOnc Pulse with Saurabh Dahiya, MD, FACP, of Stanford Medicine, and Jay Spiegel, MD, of the University of Miami, features a discussion on the link between chimeric antigen receptor (CAR)-T cell therapies and secondary T-cell malignancies. The episode follows on the heels of the US Food and Drug Administration's request to drug manufacturers of the six CAR-T therapies to make safety-related labeling changes.
2024-02-0840 min
The HemOnc PulseAditi Shastri, MD: Clinicians Need to ‘Come Together’ on TP53-Mutated MDSThis episode features a conversation between Dr. Shastri, an Assistant Professor of Medicine at the Montefiore Einstein Comprehensive Cancer Center in the Bronx, New York, and The HemOnc Pulse host, Chadi Nabhan; MD; MBA; FACP; on the latest news in myelodysplastic syndromes (MDS), including the final readout from the COMMANDS trial and the clinical implications of TP53-mutated MDS.2024-01-1823 min
The HemOnc PulseDr. Usmani Discusses Perseus, IsKia, Data Plus More Myeloma UpdatesSaad Usmani, MD, MBA, FACP, Chief of the Myeloma Service at the Memorial Sloan Kettering Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, on The HemOnc Pulse to chat about the latest research in multiple myeloma from the 65th American Society of Hematology (ASH) Annual Meeting and Exposition.
Dr. Usmani shares insights on the evolution in myeloma treatment since he first started practicing in the hematologic oncology space. He also reflects on the Perseus and IsKia trials, which were presented at ASH 2023.2023-12-1827 min
The HemOnc PulseJerald Radich, MD: AML Abstracts to Keep an Eye on at ASH 2023In this episode of The HemOnc Pulse, Jerald Radich, MD, of the Fred Hutchinson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss various abstracts on acute myeloid leukemia (AML) presented at the 2023 American Society of Hematology (ASH) Annual Meeting & Exposition. The conversation centered around menin inhibitors for the treatment of AML, the effect of measurable residual disease-positivity on transplantation outcomes, and whether age plays a role in transplantation.2023-12-1736 min
The HemOnc PulseJorge Cortes, MD, on Why Balance Is Key in CML TherapyDr. Cortes, who serves as Director of the Georgia Cancer Center at Augusta University, joins host Chadi Nabhan, MD, MBA, FACP, to chat about the “boom” in treatments for chronic myeloid leukemia (CML), and where he sees a need for balance.
Dr. Cortes discussed the evolution of tyrosine kinase inhibitors (TKIs) and the multiple generations of TKIs that are now available. Second-generation TKIs can lead to earlier and deeper responses than first-generation TKIs, he said, noting that this means patients receiving second-generation TKIs are more likely to be able to discontinue treatment.
“If I was diagnosed with CML, I would take a...2023-11-0223 min
The HemOnc PulseDr. Garcia-Manero on the Data Behind the Luspatercept ApprovalGuillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, live at the Eleventh Annual Meeting of the Society of Hematologic Oncology to discuss the phase III COMMANDS trial, the recent approval of luspatercept, and other developments in myelodysplastic syndromes (MDS) treatment and research.
Dr. Garcia-Manero spoke about the design of the phase III COMMANDS trial, which evaluated luspatercept versus epoetin alfa for the treatment of anemia in patients with lower-risk MDS who required red blood cell (RBC) transfusions but had not previously received an erythropoiesis-stimulating agent.
“The study is very interesting in...2023-09-1320 minVoices of Women PhysiciansEp 62: Building Your Proprietary Brand with Dr. Liudmila SchaferLiudmila Schafer, MD, FACP, is a board-certified and award-winning medical oncologist and founder of The Doctor Connect Professional Corporation, Helping Physicians and Established Professionals Become Proprietary Brands by using an "Organic Bravery™," a dynamic framework that helps you align passion and expertise, which includes developing proprietary business offers for physicians entrepreneurs, how to become bestseller author, how to start business, grow profitable revenue, media appearances in front of multimillion audiences, how to find speaking engagements, how to to enhance career and have professional and personal fulfillment. She strives to find methods to end "labeling" and promote equality. Dr...2023-09-0523 min
The HemOnc PulseBhavana Bhatnagar, MD, on the Molecular Revolution in AMLIn this episode of The HemOnc Pulse, Dr. Bhatnagar, an Associate Professor of Medicine at the West Virigina University Cancer Institute, reflects on how the molecular characterization of acute myeloid leukemia (AML) has evolved. She joins host Chadi Nabhan, MD, MBA, FACP, to discuss how this growing base of knowledge has impacted diagnosis, treatment, and classification.
“The most significant changes have come about as a result of improvements and refinements in the molecular characterization of AML,” Dr. Bhatnagar said.
Some of these changes include major updates in the World Health Organization and European LeukemiaNet systems.
The episode also highlights Dr. Bhat...2023-08-1025 min
The HemOnc PulseAbi Vijenthira, MD, and Anca Prica, MD, on Why Certain DLBCL Therapies May Not Be Cost EffectiveDrs. Vijenthira and Prica, both of the Princess Margaret Cancer Centre, speak with host Chadi Nabhan, MD, MBA, FACP, about their analysis on the cost-effectiveness of pola-R-CHP and second-line CAR-T in patients with DLBCL, and why its results differed from a similar study published in the journal Blood in December 2022.2023-05-1832 min
The HemOnc PulseSagar Lonial, MD, FACP, on Why This MRD Approach Is ’Premature’ in MMBlood Cancers Today Editor-in-Chief Sagar Lonial, MD, FACP, discusses how he approaches frontline therapy for multiple myeloma (MM), why he thinks certain approaches to minimal residual disease (MRD) in MM are “premature,” and the data that show why sustained MRD negativity is key, with host Chadi Nabhan, MD, MBA, FACP.2023-05-0422 min
The HemOnc PulseAlan Skarbnik, MD, Gives the Lowdown on Treating Patients with Follicular LymphomaAlan Skarbnik, MD, of Novant Health, discusses treating patients with follicular lymphoma, the nuances involved in those decisions, and why bispecifics are here to stay, with host Chadi Nabhan, MD, MBA, FACP.2023-04-2032 min
The HemOnc PulseAmer Zeidan, MBBS, MHS, on the Evolution of AML Classification, TreatmentIn this episode of The HemOnc Pulse, Amer Zeidan, MBBS, MHS, of Yale, discusses the impact of AML classification updates, the practical implications of testing for genetic alterations, and how patient characteristics inform his approach to treating AML, with host Chadi Nabhan, MD, MBA, FACP.2023-04-0626 min
the Essential Free Audiobooks in Non-Fiction, Current Affairs, Law, & PoliticsToxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice by Chadi Nabhan Md Mba FacpPlease visit https://thebookvoice.com/podcasts/1/audiobook/646579 to listen full audiobooks. Title: Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice Author: Chadi Nabhan Md Mba Facp Narrator: Chadi Nabhan Md Mba Facp Format: Unabridged Audiobook Length: 10 hours 39 minutes Release date: February 28, 2023 Ratings: Ratings of Book: 5 of Total 1 Genres: Current Affairs, Law, & Politics Publisher's Summary: For years, Monsanto declared that their product Roundup, the world’s most widely used weed killer, was safe. But that all changed in 2015, when the International Agency for Research on Cancer (IARC) analyzed data from scientific studies and concluded that gl...2023-02-2805 min
Grab the Essential Full Audiobooks in Non-Fiction, Current Affairs, Law, & PoliticsToxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice by Chadi Nabhan Md Mba FacpPlease visithttps://thebookvoice.com/podcasts/1/audiobook/646579to listen full audiobooks.
Title: Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice
Author: Chadi Nabhan Md Mba Facp
Narrator: Chadi Nabhan Md Mba Facp
Format: Unabridged Audiobook
Length: 10 hours 39 minutes
Release date: February 28, 2023
Ratings: Ratings of Book: 5 of Total 1
Genres: Current Affairs, Law, & Politics
Publisher's Summary:
For years, Monsanto declared that their product Roundup, the world’s most widely used weed killer, was safe. But that all changed in 2015, when the International Agency for Research on Cancer (IARC) analyzed data from scientific studies and concluded that glyphosate, th...2023-02-2810h 39Voices of Women PhysiciansEp 33: Learning About Essential Oils with Dr. Ann HuntingtonAnn Huntington, MD, FACP, is an Internal Medicine-trained Hospital Medicine physician. She has expertise in quality, patient safety, peer review, privileging, and credentials. Most recently, she was the medical director of over 50 hospitalist physicians during the pandemic. She believes lifestyle and integrative medicine are foundational to medical care, when used appropriately. She is the founder and CEO of Give More Naturally, LLC. With special expertise in the field of essential oils, she is launching an unbranded CME course for physicians on the safety and research of essential oils as an integrative tool. Some of the topics we di...2023-02-1428 min
The HemOnc PulseLaurie H. Sehn, MD, MPH, on the Game-Changing Bispecifics in Follicular LymphomaIn the latest episode of The HemOnc Pulse, Laurie H. Sehn, MD, MPH, Chair of the Lymphoma Tumour Group at the BC Cancer Centre for Lymphoid Cancer, talks with host Chadi Nabhan, MD, MBA, FACP, about which bispecific antibodies will change the game in follicular lymphoma treatment. Dr. Sehn also explains why the TRIANGLE study is anticipated to be practice-changing and how it may make upfront transplant obsolete in MCL.2023-02-0937 min
The HemOnc PulseSanam Loghavi, MD, Tells Us Why 2022 was a Major Year for MDSSanam Loghavi, MD, stops by The HemOnc Pulse and chats with host Chadi Nabhan, MD, MBA, FACP, about why she thinks 2022 was a major year for MDS in this latest episode of the podcast. With the unveiling of the two new MDS classification systems in the past year, Dr. Loghavi breaks down the classification models and what it means for the specialty.2023-01-2639 min
The HemOnc PulseElizabeth Brem, MD, on Which CLL Abstract From ASH 2022 Can’t Be IgnoredIn the latest episode of The HemOnc Pulse, podcast host Chadi Nabhan, MD, MBA, FACP, talks with Elizabeth Brem, MD, Clinical Associate Professor in the School of Medicine at the University of California, Irvine, off the heels of the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition. Dr. Brem discusses which chronic lymphocytic leukemia (CLL) abstracts from ASH 2022 cannot be ignored, the latest news in Richter’s transformation, and why she is moving away from ibrutinib in her own clinical practice.2023-01-1236 min
The HemOnc PulseDrs. Hagop Kantarjian and Elias Jabbour Discuss Important AML, ALL Updates From ASH 2022In the inaugural episode of The HemOnc Pulse, podcast host Chadi Nabhan, MD, MBA, FACP, talks with Hagop Kantarjian, MD, and Elias Jabbour, MD, both of the Department of Leukemia at the University of Texas MD Anderson Cancer Center. The trio cover high-impact studies, novel treatment strategies, and controversial standard-of-care approaches for AML as well as ALL that were presented at the 2022 American Society of Hematology Annual Meeting & Exposition.2022-12-1444 min
The Whole Health CureRecast: "The Heart of Cardiovascular Prevention" with Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPCIn honor of February, Heart Health Month, we are recasting our favorite conversations with heart health experts!In this episode Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPC talks about prevention of heart disease. Dr. Sperling covers a range of topics related to cardiovascular disease and its prevention. What is preventive cardiology? How can we prevent heart disease in individuals and populations? What are the risk factors for heart disease? Dr. Sperling discusses the opportunities in healthcare as it relates to cardiovascular health, and why this topic is especially relevant in the time of the pandemic...2021-02-1136 min
Radio ElshintaSilent Killer, Happy Hypoxia gejala baru Covid-19. Tidak terasa, tiba2 fatal. Bersama, DR. dr. Ari Fahrial Syam SpPD-KGEH, MMB, FINASIM, FACPSilent Killer, Happy Hypoxia gejala baru Covid-19. Tidak terasa, tiba2 fatal. Bersama, DR. dr. Ari Fahrial Syam SpPD-KGEH, MMB, FINASIM, FACP2020-08-2614 min
Hospital and Internal Medicine PodcastAn (old) New Weapon to Fight Leg Cellulitis2020-08-1311 min
The Whole Health Cure"The Heart of Cardiovascular Prevention" with Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPCThis is a very special episode - Episode # 100! THANK YOU to everyone for your continued support!In this episode Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPC talks about prevention of heart disease. Dr. Sperling covers a range of topics related to cardiovascular disease and its prevention. What is preventive cardiology? How can we prevent heart disease in individuals and populations? What are the risk factors for heart disease? Dr. Sperling discusses the opportunities in healthcare as it relates to cardiovascular health, and why this topic is especially relevant in the time of the pandemic. Dr...2020-05-1536 minHospital and Internal Medicine PodcastAcute Severe Hypertension - part 12020-04-2814 minHospital and Internal Medicine PodcastAcute Severe Hypertension - part 2Multiple treatment issues are discussed. This includes theoretical ideal blood pressure lowering rates, oral options (for hypertensive urgency and specific populations), intravenous options (for hypertensive emergency or NPO patients), specific issues with aortic dissection, coronary syndromes, acute pulmonary edema & heart failure, labetalol, esmolol, nitroglycerin, and nitroprusside.
2020-04-2816 minHospital and Internal Medicine PodcastAcute Severe Hypertension - part 3Did you know that intravenous labetalol and oral labetalol are not really similar? The great hydralazine debate. Things you must know about Clevidipine if you are going to use it.
2020-04-2714 minHospital and Internal Medicine PodcastAcute Severe Hypertension - part 4Did you know systolic and diastolic blood pressure are NOT measured by automated BP cuffs? PRES (Posterior Reversible Encephalopathy Syndrome), also known as RPLS (Reversible Posterior Leukoencephalopathy Syndrome), is something you should recognize when you see it. Brief mentions of esmolol, nitroprusside, and other topics are scattered somewhere in between musings.
2020-04-2517 minHospital and Internal Medicine PodcastA Plea For The Middle Ground With Covid192020-04-2500 minHospital and Internal Medicine PodcastInteresting Studies, Facts, & Opinions - April 2020 editionIf you wonder why good food is more important than mortality and why ordering too many unnecessary consults worsens the food and doesn't impact mortality - this episode is for you. Tramadol is not well understood by many prescribers and there are some emerging facts we all need to know. A flashback to diuretic use in congestive heart failure with fluid overload and elevated creatinine is also discussed somewhere in the mix. Ohhh...and stop systematically prescribing nicotine replacement at high dosages for all hospitalized smokers.
Stevens JP, Hatfield LA, Nyweide DJ, Landon B. Association of Variation...2020-04-2413 minHospital and Internal Medicine PodcastBalkan Reflections Forged By A Virus LockdownWorld War I was partly triggered by powerful allies of various nationalities being dragged into a Balkan conflict (nationalism, of course, was another major factor). The more recent Balkan conflict is even more preposterous - and here is my attempt to humorously explain the unexplainable.
2020-04-2310 minHospital and Internal Medicine PodcastRecent Interesting Internal Medicine Studies and Facts - December 2019Correcting Hypernatremia in adults (finally, a real study!). An option for that scary patient with hemoptysis. How many nephrons you have (and your patient has) - it matters.
2019-12-1018 min
Faculty FactoryA Faculty Factory Interview with Amy S. Gottlieb, MD, FACPToday’s podcast guest is Amy S. Gottlieb, MD, FACP. Dr. Gottlieb is Chief Faculty Development Officer, Associate Dean for Faculty Affairs, and Professor of Medicine and Obstetrics and Gynecology at University of Massachusetts Medical School-Baystate in Springfield, Mass.
2019-10-0452 minHospital and Internal Medicine PodcastAnemia of Inflammation - finally understand this common anemia that accomplished doctors often can't explainAnemia of Inflammation is also often referred to as Anemia of Chronic Disease. It is one of the most common anemias, yet often challenging to comprehend. This is an attempt is to try and simplify it.
2019-09-3009 minHospital and Internal Medicine PodcastAnemia of Inflammation - part 2If you know why red blood cells survive less (and are made less) during inflammatory conditions, and already know why ferritin increases in inflammation, and don't want to hear a lousy Iron Man plot idea - then you are good to go on skipping this episode.
2019-09-3007 minHospital and Internal Medicine PodcastAnemia of Inflammation - part 32019-09-3008 minHospital and Internal Medicine PodcastCreatine - part 1It occurs naturally in the body (because we synthesize it), it is in meat, and it is frequently used as a supplement. Since it is in you, why not understand what it is and what it does? Advice is provided on which supplement labels to particularly avoid. A brief reflection upon creatine within our brains (and the potential memory impact seen in one study) is utilized to make the point that when it comes to a performance enhancer, like creatine, it's not solely about the ramifications on muscle strength and endurance.
2019-08-2112 min
The Curbsiders Internal Medicine Podcast#166 Advocacy and Hot Topics in Healthcare Policy with Robert McLean MD, FACPJoin us for this roundtable discussion of advocacy in healthcare and a rundown of hot topics: coding and billing, the Affordable Care Act, universal healthcare, gender equity, women’s health, gun violence and more! Returning guest, Dr. Robert McLean (@rmmclean84), current president of the American College of Physicians, helps us answer questions like, What is advocacy in healthcare? What are the issues that are impacting your profession? What can your medical home do for you? He’s been heavily involved in advocacy throughout his career including testifying before Congress. Guest hosts Drs. Fatima Syed MD, MSc and Deep Shah MD, MSc...2019-08-141h 02The Curbsiders Internal Medicine Podcast#166 Advocacy and Hot Topics in Healthcare Policy with Robert McLean MD, FACPJoin us for this roundtable discussion of advocacy in healthcare and a rundown of hot topics: coding and billing, the Affordable Care Act, universal healthcare, gender equity, women’s health, gun violence and more! Returning guest, Dr. Robert McLean (@rmmclean84), current president of the American College of Physicians, helps us answer questions like, What is advocacy in healthcare? What are the issues that are impacting your profession? What can your medical home do for you? He’s been heavily involved in advocacy throughout his career including testifying before Congress. Guest hosts Drs. Fatima Syed MD, MSc and Deep Shah MD, MSc...2019-08-141h 02Hospital and Internal Medicine PodcastCreatine - part 2The replenishing of muscle ATP is one (of the several) mechanisms that creatine helps with when it comes to heavy anaerobic exercise. Other topics discussed are things to know about lab testing the kidneys while taking creatine. Thoughts on why some don't respond to creatine supplementation.
2019-08-0709 minHospital and Internal Medicine PodcastCreatine - part 3Is there a specific type of creatine to buy? What is creatine monohydrate? What is Creapure? What do some professional organizations have to say about the safety of creatine? The loading dose debate. Also dives into the several mechanisms of action for how creatine helps build muscle.
2019-08-0515 minHospital and Internal Medicine PodcastMedicare for All? (or maybe you call it Universal Healthcare or Single-Payer)Are you surprised that GoFundMe and crowdfunding are not the solution to a family healthcare crisis? How about Medicare for All? Hmmmm.....
2019-07-0247 minHospital and Internal Medicine PodcastPart 5 of Muscle and Strength Gaining Tips - The Emotional Connection and Overcoming Temporary Pain2019-04-0820 min
The Whole Health Cure"Simple Truth About Eating Healthy" with David Katz, MD, MPH, FACPM, FACP, FACLMDavid L. Katz, MD, MPH, FACPM, FACP, FACLM earned his BA degree from Dartmouth College (1984); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He completed sequential residency training in Internal Medicine, and Preventive Medicine/Public Health.
He is the founding director (1998) of Yale University’s Yale-Griffin Prevention Research Center, Immediate Past-President of the American College of Lifestyle Medicine, and Founder/President of the True Health Initiative, a non-profit organization established to promote messages about healthy, sustainable diet and lifestyle in the service of adding years to li...2019-03-1431 minHospital and Internal Medicine PodcastClostridium Difficile - part 1A deceivingly difficult topic. Not so obvious points are made about asymptomatic carriers, transmission, and who to test.
2019-01-2513 minHospital and Internal Medicine PodcastClostridium Difficile - part 2Specific initial treatment regimens are discussed. Topics include fulminant disease, Vancomycin, Fidaxomicin, Metronidazole, and recurrence rates/regimens.
2019-01-2310 minHospital and Internal Medicine PodcastClostridium Difficile - part 3Many of the latest studies in the 2017-2018 timeframe are reviewed. The importance of looking at the eosinophil count on the CBC, probiotic future directions, microbiome transplant options, antibody treatment (bezlotoxumab), "penicillin allergic" patients, and a brief mention of available testing.
2019-01-2313 minHospital and Internal Medicine PodcastLive From My Basement BathroomExperiences that taught me some lessons.
2018-12-2416 minHospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 7 - GLP-1 Agonists and DPP-4 InhibitorsGlucagon-Like Peptide 1 (GLP-1) mimetics are also referred to as the GLP-1 receptor agonists. While this talk mostly focuses on GLP-1 mechanisms and actions, the hope is you will also better understand The Dipeptidyl Peptidase-4 (DPP-4) inhibitors
The current GLP-1 Agonists include Exenatide (Byetta), Liraglutide (Victoza), Dulaglutide (Trulicity), Abiglutide (Tanzeum), Lixisenatide (Adlyxin), Semaglutide (Ozempic).
The current DPP-4 Inhibitors include Alogliptin (Nesina), Linagliptin (Tradjenta), Saxagliptin (Onglyza), Sitagliptin (Januvia).
2018-12-1716 min
The Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and moreIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part V, Peter and Tom talk about inflammation, endothelial health, and oxidative stress as they pertain to cardiovascular disease, and our attempts to monitor them using biomarkers. They also discuss a couple of very important risk factors that too few people (and doctors) know about. Tom closes the five-part series with a tragic story about his good friend that is likely all-too-common for many practicing...2018-10-191h 29
The Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part IV of V: Statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brainIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part IV, Peter and Tom review the history and current use of drugs to prevent cardiovascular disease. They also discuss why some drugs appear to be more effective than others, an in-depth conversation about niacin, cholesterol and brain health, and the futility of using CKs (creatinine kinase) and liver function tests to identify adverse effects in statins, to name a few topics in this episode.2018-10-182h 00
The Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteinsIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part III, Peter and Tom dig into HDL, why "reverse cholesterol transport" is a lot more nuanced than what most of us are taught, lipid transport, apolipoproteins, and more. In addition, this episode highlights the complexity of HDL and a discussion about the CETP inhibitor trials. We discuss: Reverse cholesterol transport [1:40]; Lipid transportation, apolipoproteins, VLDL, IDL, and LDL particles [11:00]; Remnant lipoproteins and...2018-10-171h 04
The Peter Attia DriveTom Dayspring, M.D., FACP, FNLA – Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part II, Tom provides a 101 on lipids and lipoproteins. Tom and Peter also discuss the history and techniques used to measure lipoproteins, and more. We discuss: Lipoprotein basics [1:30]; Gofman and the ultracentrifuge [5:15]; Lipoprotein structure, function, metabolism [6:45]; Lipoprotein and cholesterol measurement, and NMR technology [15:15]; LDL-C vs LDL-P and apoB [30:45]; Sterols and cholesterol synthesis [39:45]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on...2018-10-161h 26
The Peter Attia DriveThomas Dayspring, M.D., FACP, FNLA – Part I of V: an introduction to lipidologyIn this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. Part I serves as an introduction to Tom, his work, and an overview of lipid terminology. We discuss: Tom’s recent and remarkable physical transformation [6:30]; The moving stories behind Tom’s obsessions: firefighting, hockey, and, of course, lipids [20:30]; Tom’s medical background [39:30]; Producing some of the most accessible diagrams on lipids [50:00]; What are the different kinds of lipids, what do they do, and how ar...2018-10-151h 14Hospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 6 - SGLT2 InhibitorsSodium-Glucose Transporter 2 Inhibitors decrease glucose re-absorbtion. The diuretic effect, weight loss, DKA, cardiac outcomes, blood pressure, genital infections and a whole bunch of other information is discussed.
SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.
2018-09-2620 minHospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 5 - HgA1CThere is a lot more to understanding HgA1C then most realize (particularly the quality industry and big corporations).
2018-08-2619 minHospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 4 - MetforminTackles - Vitamin B12, kidney disease, CHF, cancer, Impaired Glucose Tolerance (IGT), dosing, side-effects, lactic acidosis, cost, drinkers, hypoxic patients, glucose lowering, and a few other moments of erudation.
2018-05-2825 minHospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 3 GlucagonIf you want to understand drug classes like DPP-4 inhibitors, GLP-1 (GLUCAGON-like peptide) therapies, treating hypoglycemia, and an important player among the many etiologies of Type 2 diabetes - then you must understand the basics about glucoagon.
2018-05-1608 minHospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 2 - Reversing The Disease With Lifestyle Changes2018-05-0113 minHospital and Internal Medicine PodcastType 2 Diabetes Treatment - Part 12018-05-0108 minHospital and Internal Medicine PodcastInternal Medicine Pearls #5Diuretic therapy for congestive heart failure treatment, antibiotics for diabetic osteomyelitis after foot surgery, and practical tips with new-onset seizures - is among the knowledge dropped (because, after all, school can't teach us everything).
2018-04-0333 min
Relationships 2.0 With Dr. Michelle SkeenGuest: Pankaj Vij, MD, FACP author of Turbo Metabolism: 8 Weeks to a New YouThis week on Relationships 2.0 my guest is Pankaj Vij, MD, FACP author of Turbo Metabolism: 8 Weeks to a New You
About the book:
As the modern Western lifestyle spreads around the globe, so too does metabolic syndrome — a cluster of symptoms that increases the risk of developing heart disease, stroke, diabetes, and other conditions. The good news: metabolic syndrome can be tamed by a sensible program of exercise, natural foods, stress management, and quality sleep. In this concise and lively book, Dr. Vij distills a mass of medical research into a simple, effective program for vibrant health. Avoiding fads and gi...2018-02-081h 01Hospital and Internal Medicine PodcastSome Recent Studies Worth Knowing About - February 2018Some new stuff about Vitamin D & Calcium supplementation, another about the timing of hip fracture surgery, etc
2018-02-0111 minHospital and Internal Medicine PodcastForcing Atheist Doctors to Play With God2017-12-2234 minHospital and Internal Medicine PodcastInternal Medicine Pearls #4Checking glucose levels in Type 2 Diabetes, ACE Inhibitors for women, and using Azithromycin in Asthma.
2017-11-1414 minHospital and Internal Medicine PodcastMedical Podcasts, Skiing, and Imperfect Relationship Advice2017-10-0415 minHospital and Internal Medicine PodcastPatent Foramen Ovale Evaluation and Closure After a Stroke - part 22017-09-2615 minHospital and Internal Medicine PodcastPatent Foramen Ovale Evaluation and Closure After a Stroke - part 1
2017-09-2211 minHospital and Internal Medicine PodcastThe Overhead Airplane Request for Medical Assistance - A No Win Situation2017-09-2005 minHospital and Internal Medicine PodcastA Severe Case of Healthcare Violence 2 Years Later2017-08-3117 minHospital and Internal Medicine PodcastBedbugs 4 The Dark Night Returns2017-08-3120 minHospital and Internal Medicine PodcastBedbugs 3 Live Free and Die Hard2017-08-1010 minHospital and Internal Medicine PodcastBedbugs 2 Fast and 2 Furious2017-07-3112 minHospital and Internal Medicine PodcastBedbugs - part 12017-07-1509 minHospital and Internal Medicine PodcastUrine Drug Testing - Misinterpretation is Very CommonYou know all those people on social media wanting mandatory drug testing for welfare recipients? Perhaps, reasonable in theory, if the test wasn't frequently producing false-positives and false-negatives. Making accurate clinical decisions is always challenging, but particularly with urine drug testing. The consequences of misinterpretation can be awful.
2017-05-2821 minHospital and Internal Medicine PodcastThe death of Chris Cornell and calling my doctor2017-05-2220 minHospital and Internal Medicine PodcastInternal Medicine Pearls #3A look at some new data: COPD and Oxygen use - low serum creatinine levels - BMI considerations - the RDW - the age of blood.
2017-05-1120 min
MARINA's Audio PodcastMARINA's interview with Georges C. Benjamin MD, FACP, FACEP (E) Executive Director of the APHAGeorges C. Benjamin MD, FACP, FACEP (E)Executive Director of the APHA - Public Health and PreparednessMARINA talks with Dr. Benjamin about Public Health, Pandemic Flu and Obesity.www.getreadyforflu.orgFeatured Song:"America For Life" 157 BPMWritten by MARINA & T. MarinelloProduced by MARINAAll vocals by MARINAMARINA's High-nrg Fitness Music and Workouts2009-04-0100 min